NEO/ROCH (NEO/ROCH)

Cboe Canada: NEO/ROCH · CAD

CA$15.0

+0.08 (+0.5%)· Recorded snapshot

Market cap	542.1B
Revenue (ttm)	110.7B
Net income (ttm)	21.7B
EPS (ttm)	CA$0.58
P/E (trailing)	25.7x
P/E (forward)	18.7x
Dividend	CA$0.61 (4.08%)
Volume	800
Beta	0.33

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 110.7B
Net income (ttm): 21.7B
EPS (ttm): CA$0.58
P/E (trailing): 25.7x
P/E (forward): 18.7x
Market cap: 542.1B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E18.7

P25 n/aP50 n/aP75 n/a

Trailing P/E25.7

P25 n/aP50 n/aP75 n/a

ROE38.1

P25 n/aP50 n/aP75 n/a

ROIC28.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All NEO/ROCH indicators

Market & fundamental data

Available fields

229

Groups with data

Currency

CHF

Showing 229 of 229 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Switzerland
Country code	CA
Earnings date	2026-10-28
Employees	103,249
Employees change	-356
Employees growth	-0.34%
Enterprise value	CAD 588.9B
Exchange	Cboe Canada
Financial currency	CHF
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1896
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	CA77119N1050
Last earnings date	2026-07-23
Last refreshed	2026-10-28
Market cap	CAD 542.1B
Next earnings date	2026-10-28
Price	CAD 14.96
Price currency	CAD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-27
Symbol	neo/ROCH
Website	https://www.roche.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	20.44x
Average P/E ratio (3Y)	20.61x
Average P/E ratio (5Y)	20.31x
Earnings yield	3.89%
EV/Earnings	27.05x
EV/EBIT	16.63x
EV/EBITDA	14.3x
EV/FCF	21.2x
EV/Sales	5.5x
FCF / EV yield	4.72%
FCF yield	5.13%
Forward P/E	18.68x
Graham number	4.91333
Graham upside	-67.13%
Lynch fair value	CAD 3.00
Lynch upside	-79.92%
P/(FCF - SBC) ratio	20.64x
P/(OCF - SBC) ratio	16.59x
P/B ratio	8.37x
P/E ratio	25.73x
P/FCF ratio	19.51x
P/OCF ratio	15.85x
P/S ratio	4.88x
Price / tangible book value	54.82x
Price/EBITDA ratio	12.82x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	33.12%
EBITDA margin	38.06%
Effective tax rate	18.74%
FCF margin	25.99%
Gross margin	74.17%
Operating margin	33.12%
Pretax margin	25.98%
Profit margin	19.6%
Profit per employee	CAD 210,074
Profitable quarters	47
Profitable years	23
Revenue per employee	CAD 1.1M
ROA	13.51%
ROA (5Y)	13.31%
ROCE	30.06%
ROE	38.11%
ROE (5Y)	38.06%
ROIC	28.1%
ROIC (5Y)	32.56%
SBC / revenue	1.38%
Tax / revenue	4.87%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	30.57%
EPS growth (Q)	-7.69%
EPS growth (QoQ)	25.11%
EPS growth 10Y	3.82%
EPS growth 3Y	3.87%
EPS growth 5Y	-1.14%
EPS growth years	1
FCF growth	-0.29%
FCF growth (Q)	11.9%
FCF growth (QoQ)	-37.37%
FCF growth 3Y	6.53%
FCF growth 5Y	-0.37%
Gross profit growth	-1.65%
Gross profit growth (Q)	-2.07%
Gross profit growth 3Y	0.36%
Gross profit growth 5Y	0.78%
Net income growth	30.88%
Net income growth (Q)	-7.27%
Net income growth (QoQ)	25.61%
Net income growth 3Y	3.82%
Net income growth 5Y	-2.52%
Net income growth years	1
OCF growth	0.56%
OCF growth (Q)	7.54%
OCF growth (QoQ)	-35.03%
OCF growth 10Y	3.05%
OCF growth 3Y	5.46%
OCF growth 5Y	-0.34%
Operating income growth	2.89%
Operating income growth (Q)	-0.94%
Operating income growth 3Y	3.16%
Operating income growth 5Y	1.78%
Revenue growth	-0.83%
Revenue growth (Q)	-1.25%
Revenue growth (QoQ)	-0.17%
Revenue growth 10Y	2.01%
Revenue growth 3Y	0.23%
Revenue growth 5Y	0.28%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -6.4B
Depreciation and amortization	CAD 5.3B
EBIT	CAD 36.6B
EBITDA	CAD 42.1B
EPS	CAD 0.58
Financing cash flow	CAD -23.6B
Free cash flow	CAD 27.7B
Free cash flow minus SBC	CAD 26.2B
Gross profit	CAD 82.1B
Income taxes	CAD 5.4B
Investing cash flow	CAD -14B
Net borrowing	CAD -3.4B
Net cash flow	CAD -3.7B
Net income	CAD 21.7B
Operating cash flow minus SBC	CAD 32.6B
Operating income	CAD 36.6B
Revenue	CAD 110.7B
Stock-based compensation	CAD 1.5B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	4.48
Book value per share	CAD 72.12
Debt / EBITDA	1.37
Debt / equity	0.91
Debt / FCF	2.11
Goodwill	CAD 13.1B
Interest coverage	18.24
Long-term assets	CAD 112.6B
Long-term liabilities	CAD 59.3B
Net cash (debt)	CAD -41.4B
Net cash / market cap	-7.67%
Net debt / EBITDA	0.98
Net debt / equity	0.64
Net debt / FCF	1.5
Piotroski F-Score	5
Property, plant and equipment	CAD 39.6B
Shareholders' equity	CAD 64.5B
Tangible book value	CAD 9.8B
Tangible book value per share	CAD 12.36
Total assets	CAD 172.6B
Total cash	CAD 17.1B
Total debt	CAD 58.5B
Total liabilities	CAD 108.1B
WACC	5.73%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.65
Current assets	CAD 59.9B
Current liabilities	CAD 48.8B
Current ratio	1.23
Inventory turnover	2.07
Net working capital	CAD 6B
Quick ratio	0.8
Working capital	CAD 11.6B
Working capital turnover	15.04

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.31%
Dividend growth	0%
Dividend growth years	0
Dividend payment years	1
Dividend per share	CAD 0.61
Dividend yield	4.09%
Ex-dividend date	2026-03-13
Last dividend	CAD 0.36
Payout ratio	63.22%
Shareholder yield	3.79%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 12.84
1D price change	0.54%
1M price change	10%
1M total return	10%
1W price change	7.55%
1W total return	7.55%
1Y price change	50.66%
1Y return CAGR	50.7%
1Y total return	50.66%
20-day SMA	CAD 13.82
3M price change	20.26%
3M total return	20.26%
50-day SMA	CAD 13.53
52-week high	CAD 14.96
52-week high date	2026-10-27
52-week low	CAD 9.55
52-week low date	2025-10-31
6M price change	25.19%
6M total return	25.19%
All-time high	CAD 14.96
All-time high date	2026-10-27
All-time low	CAD 8.96
All-time low date	2025-08-11
Average true range (ATR)	CAD 0.14
Average volume	503.4
Beta (5Y)	0.33
Change from 52-week high	0%
Change from 52-week low	56.65%
Change from all-time high	0%
Change from all-time low	66.96%
Change from open	1.22%
Day's gap	-0.67%
Dollar volume	CAD 11,968
High price	CAD 14.96
Low price	CAD 14.78
Monthly RSI	70.28
Open price	CAD 14.78
Position in 52-week range	100%
Previous close	CAD 14.88
Price vs 150-day SMA	16.54%
Price vs 20-day SMA	8.25%
Price vs 50-day SMA	10.57%
Relative volume	1.59
RSI	83.78
Sharpe ratio	1.31
Sortino ratio	2.18
Volume	800
Weekly RSI	70.38
YTD price change	24.98%
YTD total return	24.98%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	723.7M
Shares change (QoQ)	0.5%
Shares change (YoY)	0.31%
Shares held by insiders	9.17%
Shares held by institutions	28.86%

Deeper analysis on NEO/ROCH

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this NEO/ROCH report

Is a complete NEO/ROCH research report available?

No complete published report is available for neo/ROCH (NEO/ROCH) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

NEO/ROCH (NEO/ROCH)

Price

Financial snapshot

Fair-value bridge

Latest news · NEO/ROCH

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NEO/ROCH indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on NEO/ROCH

Frequently asked questions